← Back to headlines
EU Regulator Recommends Approval for Sanofi's Subcutaneous Blood Cancer Drug Scarlisa
The European Union regulator has given its backing to Sanofi's injectable version of a blood cancer drug, specifically recommending approval for the subcutaneous version of Scarlisa (isatuximab).
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
seeking-alphaFrench3h ago
Sanofi gains EU approval recommendation for Scarlisa subcutaneous version
Read full article →ReutersFrench4h ago
EU regulator backs Sanofi's injectable version of blood cancer drug - Reuters
EU regulator backs Sanofi's injectable version of blood cancer drug Reuters
Read full article →Coverage Timeline
First report: Reuters · 27 Mar, 13:36|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
